Evigrade
MajorSelective serotonin reuptake inhibitor (SSRI)×Selective estrogen receptor modulator (SERM)

Updated · Methodology

Mechanism

Tamoxifen is a prodrug: CYP2D6 converts it to endoxifen, one of its most active forms. Paroxetine is a strong CYP2D6 inhibitor. The data cited in the Spanish SmPCs of both drugs show a 65–75% fall in endoxifen levels with CYP2D6 inhibitors. In some studies tamoxifen efficacy dropped with paroxetine, up to higher breast cancer relapse and mortality; other studies found no such effect, as the FDA label notes.

Symptoms

Tumour progression on imaging after 6–12 months.

Management

Avoid paroxetine during tamoxifen therapy where possible, as the Spanish SmPCs of both drugs require. The FDA label advises an antidepressant with little or no CYP2D6 inhibition. The Spanish SmPC describes venlafaxine as a relatively weak CYP2D6 inhibitor. Sertraline also inhibits CYP2D6 (mild to moderate), and escitalopram doubled desipramine and metoprolol levels in studies. Fluoxetine and bupropion are strong CYP2D6 inhibitors, like paroxetine. If depression does not respond to the switch, oncology and psychiatry agree the regimen together.

Check the full regimen, not just this pair

Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Sources

Other interactions with Paroxetine

Other interactions with Tamoxifen